- page

Scroll to explore

Scroll back top

Domain at the BioTrinity 2020 digital conference

Domain Therapeutics acquires Prestwick Chemical and Neurofit to bolster next stage of growth

4 February 2020

Domain Therapeutics is granted European and US patent for biosensors assessing GPCR trafficking

13 January 2020

Domain Therapeutics secures €6 million ($6.7M) debt financing

13 January 2020

Domain at the JP Morgan Healthcare conference

17 December 2019

Domain Therapeutics and Pr Michel Bouvier (IRIC Montreal) receive the RSRI award for bioSens-All™ ...

30 September 2019

Domain Therapeutics reaches two milestones in multi-target research collaboration with Boehringer In...

11 September 2019

Domain Therapeutics invests in Ermium Therapeutics to develop first-in-class CXCR4 candidate for aut...

Domain Therapeutics appoints Xavier Leroy as chief technology officer

Domain Therapeutics strengthens its scientific advisory board with leading GPCR and disease experts